CDNA

CDNA Operating Cash Flow Growth

428.48%TTM

Period ending:

CDNA TTM Cash from Operations YoY %%
CDNA TTM Cash from Operations YoY %22273.21%-8440.26%
2014-12-312026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

CDNA operating cash flow growth history

Year-over-year operating cash flow growth rate. The available trailing twelve months (ttm) series contains 47 observations from Dec 31, 2014 to Jun 30, 2026.

Caredx Inc Operating Cash Flow Growth — Trailing twelve months (TTM)
Period endingOperating Cash Flow Growth
428.4844%
172.4417%
10.471%
447.1587%
218.7563%
177.9029%
306.9176%
375.6201%
-5,467.9856%
-1,008.7419%
27.1445%
90.0134%
101.3367%
56.5339%
-30.8127%
-73.5856%
-81.5698%
-349.7199%
-157.7129%
-164.6839%
-155.6966%
6,541.8605%
1,307.3312%
7,966.3462%
19,300.9434%
100.8028%
30.8959%
103.8268%
100.9839%
55.6769%
71.9927%
46.4323%
24.1445%
29.2174%
13.4116%
12.7193%
26.277%
-14.347%
-69.4319%
-168.3595%
-170.1823%
-228.5651%
-191.1045%
-83.2487%
-504.195%
-900%
-513.5531%

Compare operating cash flow growth

All CDNA financial metrics · CDNA stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.